Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

ANAPTYSBIO, INC. (ANAB) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

ANAPTYSBIO, INC. (ANAB), most recent 12 months reported: revenue $237.61M, net income $195.72M, free cash flow $19.61M. Latest balance sheet on file: liquid cash $164.14M. From SEC filings. Others in Pharmaceutical Preparations: Schrodinger, Inc. · Syndax Pharmaceuticals, Inc. · RHYTHM PHARMACEUTICALS, INC. · PHATHOM PHARMACEUTICALS, INC. · IDEAYA Biosciences, Inc. · PUMA BIOTECHNOLOGY, INC. · AKEBIA THERAPEUTICS, INC. · VANDA PHARMACEUTICALS INC.

Stock screener

Watchlist